Middle East News Dispatch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Dispatch.

Press releases published on September 22, 2026

Sep. 22, 2026

HealthNet MEA to Commercialise COMIDE ER® (Methylphenidate ER) in UAE Under Exclusive Agreement with Anxo Pharmaceutical

Indeterminate EIN Presswire

Sep. 22, 2026

إكس أس دوت كوم" توسّع حضورها في المنطقة العربية من خلال رعايتها لمعرض قطر المالي

Indeterminate EIN Presswire

Sep. 22, 2026

i-ESG Expands Collaboration with Global Sustainability Initiatives And International Development Finance Institutions

Indeterminate EIN Presswire

Sep. 22, 2026

Greenland Mines Applauds Formal Signing of U.S.-Denmark-Greenland Security Agreement at United Nations

Indeterminate GlobeNewswire

Sep. 22, 2026

SK pharmteco und GEMMABio bauen ihre Zusammenarbeit im Bereich der Herstellung von Arzneimitteln für seltene Erkrankungen nach einem wichtigen Meilenstein in der klinischen Studie zur spinalen Muskelatrophie (SMA) aus

Indeterminate GlobeNewswire

Sep. 22, 2026

SK pharmteco et GEMMABio renforcent leur collaboration dans la fabrication de traitements pour les maladies rares après une étape clé de l’essai clinique consacré à l’amyotrophie spinale (SMA)

Indeterminate GlobeNewswire

Sep. 22, 2026

Dynacor Group Announces October 2026 Dividend

Indeterminate GlobeNewswire

Sep. 22, 2026

Groupe Dynacor déclare son dividende pour octobre 2026

Indeterminate GlobeNewswire

Sep. 22, 2026

GFG Outlines New Large-Scale Gold-in-Till Anomaly at Goldarm; Expands Regional Exploration Program

Indeterminate GlobeNewswire

Sep. 22, 2026

Cyabra Recognized as the AI-powered Enterprise Solution of the Year by the 2026 Tech Ascension Awards

Indeterminate GlobeNewswire

Sep. 22, 2026

Kirkland Lake Discoveries Corp. Announces Upsized Brokered Private Placement

Indeterminate GlobeNewswire

Sep. 22, 2026

SK pharmteco and GEMMABio Expand Rare Disease Manufacturing Collaboration Following Important Spinal Muscular Atrophy (SMA) Clinical Trial Milestone

Indeterminate GlobeNewswire

Sep. 22, 2026

Nexxen U Launches ‘Data for the Converged Media World,’ Building on Program Momentum and Industry Demand

Indeterminate GlobeNewswire

Sep. 22, 2026

AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicines’ Daraxonrasib

Indeterminate GlobeNewswire

Sep. 22, 2026

Palisade Bio Receives FDA Clearance of IND for PALI-2108 in Crohn’s Disease, Expanding Phase 2 Development Across IBD

Indeterminate GlobeNewswire

Sep. 22, 2026

Polyrizon Enrolls First Patient in U.S. Clinical Study of NASARIX (PL-14) Allergy Blocker

Indeterminate GlobeNewswire

Sep. 22, 2026

Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome

Indeterminate GlobeNewswire

Sep. 22, 2026

Vistagen Announces Preliminary Positive Data from Open-Label Extension Portion of PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder

Indeterminate GlobeNewswire

Sep. 22, 2026

Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium

Indeterminate GlobeNewswire

Sep. 22, 2026

Clene to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire